[Catecholamine determination in plasma using high performance liquid chromatography with electrochemical detection. Application to a rapid diagnosis of phaeochromocytoma (author's transl)].

M A Devynck; J L Elghozi; K H Le Quan-Bui; P Meyer

PubMed · 7402921

[Catecholamine determination in plasma using high performance liquid chromatography with electrochemical detection. Application to a rapid diagnosis of phaeochromocytoma (author's transl)].

M A Devynck·J L Elghozi·K H Le Quan-Bui·P Meyer

Abstract

The advantages of this technique are rapidity (performed in less than twenty minutes), reproductibilitky, and low cost. Chemical manipulation of plasma is unnecessary to diagnose phaeochromocytoma as shown in two examples. We propose therefore introduction of this technique in clinical investigation of hypertensive patients.

Explore related subjects

Adrenal Gland Neoplasms Catecholamines Chromatography, High Pressure Liquid Electrochemistry Humans Hypertension Pheochromocytoma English Abstract Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

M A Devynck, J L Elghozi, K H Le Quan-Bui, P Meyer. [Catecholamine determination in plasma using high performance liquid chromatography with electrochemical detection. Application to a rapid diagnosis of phaeochromocytoma (author's transl)].. https://pubmed.ncbi.nlm.nih.gov/7402921/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts.

BACKGROUND: Topotecan is a topoisomerase I inhibitor with activity against xenografts of childhood solid tumors and established clinical activity against neuroblastoma and rhabdomyosarcoma. We have studied the relationship between systemic exposure to and the antitumor activity of topotecan lactone (the active form of the drug) in the xenograft models. Furthermore, we determined whether the responses seen in these models occur at systemic exposure levels that are tolerable in children. METHODS: Neuroblastoma xenografts derived from the tumors of six different patients were established subcutaneously in immune-deprived mice. Topotecan was administered by intravenous bolus injection 5 days a week for 2 consecutive weeks, repeated every 21 days for three cycles. The minimum daily doses that induced complete responses (CRs) and partial responses (PRs) were determined. Topotecan lactone pharmacokinetic studies were performed in both tumor-bearing and nontumor-bearing mice. RESULTS: The minimum doses associated with CRs and PRs in four of the six neuroblastoma xenografts were 0.61 and 0.36 mg/kg body weight, respectively. The topotecan lactone single-day systemic exposures associated with these doses were 88 and 52 ng x hr/mL, respectively. There was an approximately sixfold difference in topotecan lactone systemic exposure (290 ng x hr/mL versus 52 ng x hr/mL) associated with achieving CRs in the least-sensitive and most-sensitive tumors, respectively. CONCLUSIONS: Neuroblastoma xenografts are highly sensitive to topotecan therapy, and responses in mice are achieved at systemic exposures similar to those that are clinically effective and tolerable in children. These results support the concept of deriving preclinical data relating systemic exposure to antitumor activity in xenograft models. Such data may be valuable in making informed decisions regarding the clinical development of new agents.

Adrenal Gland Neoplasms↗

PubMed1998

[Panic disorder with agoraphobia].

Explore the source record for details and available documents.

Adrenal Gland Neoplasms↗

PubMed1998

Developmental regulation of the cm2 muscarinic acetylcholine receptor gene: selective induction by a secreted factor produced by embryonic chick retinal cells.

The expression of the cm2 muscarinic acetylcholine receptor gene increases dramatically in chick retina during embryonic development in vivo. A similar developmental increase in cm2 expression occurs in embryonic chick retinal cells in culture. Conditioned medium from mature, but not young, retinal cultures contains a secreted factor that causes a selective increase in expression of cm2, but not cm3 or cm4, receptors. The secreted factor has been partially purified from serum-free medium, is protease-sensitive, and has a molecular weight >10 kDa. The cm2-inducing factor stimulates expression of a cm2 promoter/luciferase reporter gene, demonstrating that the increase in cm2 expression is attributable to increased gene transcription. Incubation of retinal cells with 14 identified neurotrophic and growth factors did not increase cm2 expression, suggesting that a novel developmentally regulated secreted factor mediates the subtype-specific induction of the cm2 receptor gene in retina.

Adrenal Gland Neoplasms↗